ECE2021 Audio Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (223 abstracts)
1Virgen de la Victoria Hospital, Endocrinology and Nutrition, Málaga, Spain; 2Torrecárdenas University Hospital, Endocrinology and Nutrition, Almería, Spain
Introduction
Dyslipidemia is a major cardiovascular risk factor, being its detection and control essential due to risk of serious complications. Numerous trials have demonstrated its relationship with T2D, but it has not been so well studied in T1D.
Objective
To obtain information about relationship between dyslipidemia and T1D and analyze its prevalence and control in a sample of patients.
Material and methods
Retrospective descriptive observational study that analyzes data from 235 patients with DM1 in Endocrinology Consultation at Virgen de la Victoria Hospital in Malaga.
Results
50.6% were women, with a mean age of 34.59 ± 12.6 years; BMI 25.47 ± 4.27 kg/m2 and diabetes of 18.09 ± 10.15 years of evolution. From all of them, 93 (39.6%) had dyslipidemia with mean analytical parameters: glycemia 159 ± 74.4 mg/dl, HbA1c 8.6 ± 7.5%, total cholesterol 179.2 ± 7.5 mg/dl, HDL 59.9 ± 36.6 mg/dl, LDL 106.4 ± 76.9 mg/dl, triglycerides 104 ± 216.5 mg/dl. Only 74 (79.6%) received lipid-lowering treatment: 71 (76.3%) statins; 2 (2.2%) statins plus ezetimibe and 1 (1.1%) fenofibrate; with results at 6 months of: CT 163 ± 32 mg/dl, HDL 57 ± 16 mg/dl, LDL 88 ± 24 mg/dl, TG 90 ± 47 mg/dl. From them 17 (22.97%) achieved LDL < 70 mg/dl; 35 (47.29%) presented figures between 70100 mg/dl and 22 (29.79%) LDL > 100 mg/dl. The sum of patients in treatment with LDL < 100 mg/dl was 52 (70.26%). In addition, they presented a higher percentage of comorbidities compared to non-dyslipidemic patients: hypertension 43 (18.3%) patients with dyslipidemia compared to 6.3% of non-dyslipidemic patients, smoker 29.8% vs 27.5%; taking antiaggregant 19.6% vs 8.5%; and complications: retinopathy 15.3% vs 9.2%; diabetic kidney diseases 13.2% vs 12.7%; neuropathy 3.8% vs 3.5% and a history of CVD 3% vs 0.7%.
Conclusion
There is a significant relationship between dyslipidemia and age, DM1 evolution time and BMI but not HbA1c. Furthermore, it is more frequent in those patients who present other cardiovascular risk factors.